Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-006335

Chief Scientific Officer sold 1,698 shares at $9.00 ($15,282)

  • Chief Scientific Officer acquired 1,698 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2025-03-24 Option exercise 10b5-1 +1,698 $6.32 $10,731 1,281,222 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2025-03-24 Sale 10b5-1 −1,698 $9.00 $15,282 1,279,524 D: show line 2 in the form
Open-market sales · 1,698 sh · avg $9.00 · $15,282

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2025-03-24 Option exercise · Stock Option (Right to Buy) 10b5-1 −1,698 68,412 D: show line 3 in the form
Loading xslF345X05/form4.xml…